Organogenesis Holdings Inc. financial data

Symbol
ORGO on Nasdaq
Industry
Pharmaceutical Preparations
Location
85 Dan Road, Canton, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Avista Healthcare Public Acquisition Corp. (to 12/10/2018)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305 % +7.48%
Quick Ratio 33.4 % -2.94%
Debt-to-equity 59.1 % -11.5%
Return On Equity 0.32 % -82.7%
Return On Assets 0.19 % -82.8%
Operating Margin -0.27 % -109%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares -4.33%
Common Stock, Shares, Outstanding 126M shares -4.25%
Entity Public Float 200M USD -15.2%
Common Stock, Value, Issued 13K USD 0%
Weighted Average Number of Shares Outstanding, Basic 132M shares +0.34%
Weighted Average Number of Shares Outstanding, Diluted 132M shares -0.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 482M USD +11.3%
Cost of Revenue 116M USD +8.7%
Research and Development Expense 50.3M USD +13.3%
Operating Income (Loss) -1.28M USD -110%
Nonoperating Income (Expense) -1.52M USD +28.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.81M USD -127%
Income Tax Expense (Benefit) -3.67M USD -167%
Net Income (Loss) Attributable to Parent 861K USD -82.6%
Earnings Per Share, Basic -0.01 USD/shares -125%
Earnings Per Share, Diluted -0.01 USD/shares -125%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 136M USD +30.6%
Accounts Receivable, after Allowance for Credit Loss, Current 110M USD +34%
Inventory, Net 26.2M USD -7.2%
Assets, Current 286M USD +27.1%
Deferred Income Tax Assets, Net 39.5M USD +40.9%
Property, Plant and Equipment, Net 89.1M USD -23.3%
Operating Lease, Right-of-Use Asset 37.1M USD -7.5%
Intangible Assets, Net (Excluding Goodwill) 12.5M USD -21.4%
Goodwill 28.8M USD 0%
Other Assets, Noncurrent 5.01M USD -16.4%
Assets 498M USD +8.23%
Accounts Payable, Current 28.9M USD -5.9%
Employee-related Liabilities, Current 23.8M USD +30.3%
Accrued Liabilities, Current 39.5M USD +31.2%
Liabilities, Current 77.5M USD -3.77%
Operating Lease, Liability, Noncurrent 25.2M USD +0.58%
Other Liabilities, Noncurrent 894K USD -26.3%
Liabilities 113M USD -37.9%
Retained Earnings (Accumulated Deficit) -40.1M USD +2.1%
Stockholders' Equity Attributable to Parent 263M USD -5.66%
Liabilities and Equity 498M USD +8.23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD -100%
Net Cash Provided by (Used in) Financing Activities -2.61M USD -111%
Net Cash Provided by (Used in) Investing Activities -2.22M USD +70.6%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 126M shares -4.23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15M USD -8.05%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 136M USD +30.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.38M USD +8.18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 50M USD +20.9%
Operating Lease, Liability 138M USD +176%
Depreciation 10.8M USD +50.5%
Payments to Acquire Property, Plant, and Equipment 2.22M USD -70.6%
Lessee, Operating Lease, Liability, to be Paid 147M USD +152%
Property, Plant and Equipment, Gross 140M USD +7.55%
Operating Lease, Liability, Current 4.27M USD -9.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.33M USD +4.57%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 870K shares -13%
Unrecognized Tax Benefits 873K USD -46.1%
Operating Lease, Payments 2.72M USD +10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.4M USD -30.8%
Depreciation, Depletion and Amortization 3.57M USD +40.3%
Deferred Tax Assets, Net of Valuation Allowance 39.5M USD +40.9%
Interest Expense 2.08M USD +16.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%